ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 178 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $0 | – | 600 | -25.0% | 0.00% | – |
Q3 2021 | $0 | -100.0% | 800 | -78.9% | 0.00% | -100.0% |
Q2 2021 | $13,000 | -92.0% | 3,800 | -71.2% | 0.00% | -85.7% |
Q1 2021 | $162,000 | +102.5% | 13,200 | +112.8% | 0.01% | +133.3% |
Q4 2020 | $80,000 | +300.0% | 6,202 | +343.0% | 0.00% | +50.0% |
Q4 2018 | $20,000 | -44.4% | 1,400 | -6.7% | 0.00% | 0.0% |
Q3 2018 | $36,000 | +24.1% | 1,500 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $29,000 | – | 1,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 523,280 | $10,722,007 | 12.30% |
RTW INVESTMENTS, LP | 17,687,772 | $362,422,448 | 7.65% |
Logos Global Management LP | 1,975,000 | $40,467,750 | 5.40% |
ACUTA CAPITAL PARTNERS, LLC | 362,000 | $7,417,380 | 4.97% |
New Leaf Venture Partners, L.L.C. | 118,242 | $2,422,779 | 3.11% |
MAVERICK CAPITAL LTD | 5,629,970 | $115,358,085 | 2.60% |
Ghost Tree Capital, LLC | 295,000 | $6,044,550 | 1.99% |
Frazier Life Sciences Management, L.P. | 1,403,013 | $28,747,736 | 1.91% |
Ikarian Capital, LLC | 654,726 | $13,415,335 | 1.61% |
Boxer Capital, LLC | 1,466,051 | $30,039,385 | 1.60% |